1. Home
  2. HUSA vs NRSN Comparison

HUSA vs NRSN Comparison

Compare HUSA & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUSA
  • NRSN
  • Stock Information
  • Founded
  • HUSA N/A
  • NRSN 2017
  • Country
  • HUSA United States
  • NRSN Israel
  • Employees
  • HUSA N/A
  • NRSN N/A
  • Industry
  • HUSA Oil & Gas Production
  • NRSN Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUSA Energy
  • NRSN Health Care
  • Exchange
  • HUSA Nasdaq
  • NRSN Nasdaq
  • Market Cap
  • HUSA 16.9M
  • NRSN 17.8M
  • IPO Year
  • HUSA N/A
  • NRSN 2021
  • Fundamental
  • Price
  • HUSA $1.67
  • NRSN $1.09
  • Analyst Decision
  • HUSA
  • NRSN Hold
  • Analyst Count
  • HUSA 0
  • NRSN 1
  • Target Price
  • HUSA N/A
  • NRSN N/A
  • AVG Volume (30 Days)
  • HUSA 501.1K
  • NRSN 374.5K
  • Earning Date
  • HUSA 11-14-2024
  • NRSN 12-18-2024
  • Dividend Yield
  • HUSA N/A
  • NRSN N/A
  • EPS Growth
  • HUSA N/A
  • NRSN N/A
  • EPS
  • HUSA N/A
  • NRSN N/A
  • Revenue
  • HUSA $640,348.00
  • NRSN N/A
  • Revenue This Year
  • HUSA N/A
  • NRSN N/A
  • Revenue Next Year
  • HUSA N/A
  • NRSN N/A
  • P/E Ratio
  • HUSA N/A
  • NRSN N/A
  • Revenue Growth
  • HUSA N/A
  • NRSN N/A
  • 52 Week Low
  • HUSA $0.96
  • NRSN $0.51
  • 52 Week High
  • HUSA $2.57
  • NRSN $2.33
  • Technical
  • Relative Strength Index (RSI)
  • HUSA 58.68
  • NRSN 47.35
  • Support Level
  • HUSA $1.56
  • NRSN $1.01
  • Resistance Level
  • HUSA $2.06
  • NRSN $1.13
  • Average True Range (ATR)
  • HUSA 0.17
  • NRSN 0.09
  • MACD
  • HUSA 0.04
  • NRSN -0.01
  • Stochastic Oscillator
  • HUSA 51.25
  • NRSN 27.27

About HUSA Houston American Energy Corporation

Houston American Energy Corp is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its properties, and operations, are in the U.S. Permian Basin, the U.S. Gulf Coast region, particularly Texas and Louisiana, and the South American country of Colombia. The company's exploration and development projects are focused on existing property interests, and future acquisition of additional property interests, in the Texas Permian Basin, the onshore Texas and Louisiana Gulf Coast region, and the South American country of Colombia. The Company majorly has operations in two geographical areas, the United States and Colombia.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: